-+ 0.00%
-+ 0.00%
-+ 0.00%
Bukwang Pharm Hosts R&D Day to Outline Research Strategy
Share
Listen to the news
Bukwang Pharm Hosts R&D Day to Outline Research Strategy
  • Bukwang Pharm will host its R&D Day on Nov. 24, 2026, at 9:30 a.m., focusing on open innovation and research strategy.
  • The program includes Contera Pharma's R&D progress and an introduction to ThreePoint Therapeutics.
  • Attendance will be available at its central research institute or through a live Zoom webinar.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bukwang Pharm. Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261117800286), on November 17, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending